Key result
Takotsubo cardiomyopathy associated with myasthenia gravis exacerbation carries 17.5% mortality and high critical care needs.
Why the study?
The clinical features and outcomes of Takotsubo cardiomyopathy associated with myasthenia gravis remained unclear.
Does the apical subtype of Takotsubo cardiomyopathy differ from the non-apical subtype in clinical features and outcomes among patients with myasthenia gravis?
Systematic Review (n=40)
Does the apical subtype of Takotsubo cardiomyopathy differ from the non-apical subtype in clinical features and outcomes among patients with myasthenia gravis?
No takes yet. Share an insight, caveat, or question.
Takotsubo cardiomyopathy associated with myasthenia gravis exacerbation is a highly morbid condition with 17.5% mortality and frequent need for mechanical ventilation, highlighting the need for routine cardiac screening during myasthenic crises even without chest pain.
Background Takotsubo cardiomyopathy (TTC) is a stress-induced cardiac disorder characterized by transient left ventricular dysfunction. Myasthenia gravis (MG), an autoimmune neuromuscular disease, can precipitate TTC during exacerbations such as myasthenic crises. However, the clinical features and outcomes of TTC associated with MG remain unclear. Methods We conducted a systematic review by the PRISMA guidelines. A comprehensive search of PubMed, Web of Science, and Google Scholar was performed up to May 31, 2025, using terms related to TTC and MG. Case reports and series were included if they described patients with confirmed diagnoses of both MG and TTC, with MG exacerbation occurring at the time of TTC onset. Data were extracted and compared between apical and non-apical TTC subtypes. Statistical analyses included the Mann-Whitney U test and chi-squared or Fisher’s exact test, as appropriate. Results A total of 38 articles comprising 40 cases were included. The median age was 69 years; 67.5% of the participants were female. Apical TTC was the most common subtype (71.8%). Myasthenic crisis was the most frequent TTC trigger (37.5%), while chest pain was reported in only 17.5% of cases. Mechanical ventilation and ICU admission were required in 95% and 97.4% of cases, respectively. Overall mortality was 17.5%. No significant differences were found between TTC subtypes; apical cases showed numerically higher troponin levels, which should be interpreted cautiously. Conclusions TTC associated with MG exacerbation is a rare but serious condition with high rates of respiratory failure, ICU admission, and mortality. Emergency and critical care physicians should suspect TTC in MG patients presenting with hemodynamic instability or ECG abnormalities, even in the absence of chest pain.
Itagaki et al. (2026) conducted a systematic review in Patients with myasthenia gravis experiencing exacerbation (including myasthenic crisis) and confirmed Takotsubo cardiomyopathy (n=40). None (observational synthesis of case reports) was evaluated on Overall mortality from TTC associated with MG exacerbation. Takotsubo cardiomyopathy associated with myasthenia gravis exacerbation had an overall mortality of 17.5% with high rates of mechanical ventilation (95%) and ICU admission (97.4%) in a systematic review of 40 cases.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: